ATP 2016

Summary

• Small dose differences make a difference (clinically)  (MR linac)  (Proton Beam Therapy) • Keep talking – dialogue = 2 way conversation • Multi-criteria optimisation (MCO) – improved individualisation • More data needed on normal tissue toxicity dose response

• Dose accumulation – VoxTox 

Needs automatic OAR segmentation & other computing

• Biological variation in normal tissue sensitivity 

Could we convolve a biological measure of individual normal tissue radiosensitivity with the physical dose plan